• Info
  • Insider Ownership

Insider Trading & Ownership of Juvenescence US Corp.

Location
Princeton, NJ
Summary
The estimated value of insider holdings of Juvenescence US Corp. is at least $9,704,025 dollars as of 22 Mar 2023. Juvenescence US Corp. is the Director, 10%+ Owner of AgeX Therapeutics, Inc. and owns shares of Serina Therapeutics, Inc. (SER) stock worth about $9.7M.
Signature
/s/ David Gill, Vice President and Treasurer
All Insider Reports
All Insider Reports

Notify me when Juvenescence US Corp. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Juvenescence US Corp.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SER Serina Therapeutics, Inc. Director, 10%+ Owner $9,704,025 14 Mar 2023

There are no insider transactions reported by Juvenescence US Corp.